YMAB(Delisted)
Y-mAbs TherapeuticsยทNASDAQ
--
--(--)
YMAB Profile
Y-Mabs Therapeutics, Inc.
A company that develops novel antibody-based therapeutic products for the treatment of cancer
202 Carnegie Center, Suite 301, Princeton, NJ 08540
--
Y-mAbs Therapeutics, Inc., was incorporated under the laws of the State of Delaware on April 30, 2015. The Company is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer. The company is leveraging proprietary radioimmunotherapy and antibody platforms and expertise to develop a broad portfolio of innovative drugs.
